Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.

Nygren P, Hande K, Petty KJ, Fedgchin M, van Dyck K, Majumdar A, Panebianco D, de Smet M, Ahmed T, Murphy MG, Gottesdiener KM, Cocquyt V, van Belle S
Cancer Chemother Pharmacol. 2005 55 (6): 609-16

PMID: 15723220 · DOI:10.1007/s00280-004-0946-3

MeSH Terms (17)

Administration, Oral Aged Antiemetics Antineoplastic Agents, Phytogenic Aprepitant Cross-Over Studies Docetaxel Female Humans Infusions, Intravenous Male Metabolic Clearance Rate Middle Aged Morpholines Nausea Neoplasms Taxoids

Connections (1)

This publication is referenced by other Labnodes entities: